Disposable Bioreactors II pp 239-272 | Cite as
An Approach to Quality and Security of Supply for Single-Use Bioreactors
- 1 Citations
- 2.4k Downloads
Abstract
Single-use systems (also referred to as disposables) have become a huge part of the bioprocessing industry, which raised concern in the industry regarding quality and security of supply. Processes must be in place to assure the supply and control of outsourced activities and quality of purchased materials along the product life cycle. Quality and security of supply for single-use bioreactors (SUBs) are based on a multidisciplinary approach. Developing a state-of-the-art SUB-system based on quality by design (QbD) principles requires broad expertise and know-how including the cell culture application, polymer chemistry, regulatory requirements, and a deep understanding of the biopharmaceutical industry. Using standardized products reduces the complexity and strengthens the robustness of the supply chain. Well-established supplier relations including risk mitigation strategies are the basis for achieving long-term security of supply. Well-developed quality systems including change control approaches aligned with the requirements of the biopharmaceutical industry are a key factor in supporting long-term product availability. This chapter outlines the approach to security of supply for key materials used in single-use production processes for biopharmaceuticals from a supplier perspective.
Keywords
Change control Qualification Quality by design Risk management Security of supply Single-use bioreactor Sourcing strategies StandardizationAbbreviations
- CPP
Critical process parameter
- CQA
Critical quality attribute
- DoE
Design of experiments
- EP
European pharmacopeia
- FDA
Food and Drug Administration
- FMEA
Failure mode effect analysis
- GMP
Good manufacturing practice
- ICH
International Committee Harmonization
- LLDPE
Linear low-density polyethylene
- PAT
Process analytical technology
- PE
Polyethylene
- QbD
Quality by design
- SUB
Single-use bioreactor
- URS
User requirements specifications
- USP
US pharmacopeia
References
- 1.Johnson B (2012) Supply chain security: Pfizer’s approach. http://medxu.com/goc/files/2010/11/Johnson_Global-Complex-Supply-Chain.pdf. Accessed 20 Oct 2012
- 2.Rios M (2011) Manufacturing management and analytical strategies for efficient bioprocessing. Bioprocess Int 9(9):10Google Scholar
- 3.ICH (2009) Harmonised tripartite guideline, pharmaceutical development Q8(R2). ICH. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf. Accessed 20 Oct 2012
- 4.ICH (2005) Harmonised tripartite guideline, quality risk management Q9. ICH. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf. Accessed 20 Oct 2012
- 5.ICH (2008) Harmonised tripartite guideline, pharmaceutical quality system Q10. ICH. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf. Accessed 20 Oct 2012
- 6.Johnston R, Lambert J, Strump E (2012) An industry perspective on quality by design. Bioprocess Int 10(3):26–35Google Scholar
- 7.Vasile C (2000) Handbook of polyolefins 2nd edn. In: Vasile C (ed), Marcel Dekker, Inc., New York. pp 517–560Google Scholar
- 8.Vanhamel S, Masy C (2001) Production of disposable bags: a manufacturer’s report. In: Eibl R, Eibl D (eds) Single-use technology in biopharmaceutical manufacture. Wiley, New York, pp 114–134Google Scholar
- 9.Altaras GM, Eklund C, Ranucci C, Maheshwari G (2007) Quantitation of interaction of lipids with polymer surfaces in cell culture. Biotechnol Bioeng 96(5):999–1007Google Scholar
- 10.Colton R, Sette A, Martin J, St. Laurent j, Hockstad M, Lehman T, Murphy T, Pembleton B, Potheir N, Stover J, Swisher L (2007) Recommendations for extractables and leachabales testing. Part I: introduction. Regulatory issues and risk assessment. Bioprocess Int 5(11):36–44Google Scholar
- 11.Colton R, Sette A, Martin J, St. Laurent j, Hockstad M, Lehman T, Murphy T, Pembleton B, Potheir N, Stover J, Swisher L (2008) Recommendations for extractables and leachables testing. Part 2: executing a program. Bioprocess Int 6(1):44–53Google Scholar
- 12.Barbaroux M, Sette A (2006) Properties of materials used in single-use flexible containers: requirements and analysis. Biopharm Int pp 18–29. http://www.biopharminternational.com/biopharm/article/articleDetail.jsp?id=423541&sk=&date=&pageID=2. Accessed 20 Oct 2012
- 13.Wildemann H (2004) Risikoorientiertes Lieferantenmanagement. Vortrag. In: Materialkostensenkungsseminar, MünchenGoogle Scholar
- 14.Wildemann H (2006) Risikomanagement und Rating, MünchenGoogle Scholar
- 15.Wildemann H (2010) Risikomanagement im Mittelstand, MünchenGoogle Scholar
- 16.Zawisla T (2008) Risikoorientiertes lieferantenmanagement. TCW Transfer-Centrum GmbH & Co. KG, München.Google Scholar
- 17.Wieczorek E (2012) Emerging risks a strategic management guide. In: Raimbault C, Barr A, Surrey F (eds) Burlington, GowerGoogle Scholar
- 18.BME, German association of purchasing and supply chain (2012) Prof. Dr. Ralph Schuman, Director contractual management institute, SRH Hochschule, Berlin Beschaffung aktuell 07/08/2012: 28–29Google Scholar
- 19.Beck G, Schenerman M, Dougherty J, Cordoba-Rodriguez R, Joneckis C, Mire-Sluis A, McLeod LD (2009) Raw material control strategies for bioprocesses. Bioprocess Int 9:18–33Google Scholar
- 20.ISO 9001 (2008) Quality management systems—Requirements.Google Scholar
- 21.Global Harmonization Task Force (2008) Quality management system: medical devices—guidance on the control of products and services obtained from Suppliers GHTF/SG3/N17:2008Google Scholar